These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3992517)

  • 1. Discrepancy in fibrinolytic response to desmopressin as compared to venous occlusion--a preliminary report.
    Nilsen DW; Andersen P; Hjermann I; Godal HC
    Thromb Haemost; 1985 Feb; 53(1):160. PubMed ID: 3992517
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative studies on the activation of the fibrinolytic system by venous stasis and the administration of DDAVP].
    Huyke R; Vogel G; Lauten G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):480-3. PubMed ID: 6083914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Coagulo-fibrinolytic response to intranasal administration of low dose desmopressin acetate (DDAVP) in normal and hemophiliac subjects].
    Kakishita E; Uomoto M; Nishida K; Hara M; Nagai K
    Rinsho Byori; 1982 Nov; 30(11):1230-4. PubMed ID: 7182595
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to fibrinolytic activity and factor VIII-related antigen to stimulation with desmopressin in hyperlipoproteinemia.
    Brommer EJ; Gevers Leuven JA; Barrett-Bergshoeff MM; Schouten JA
    J Lab Clin Med; 1982 Jul; 100(1):105-14. PubMed ID: 6806418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of DDAVP and venous occlusion on the release of tissue-type plasminogen activator and von Willebrand factor in patients with panhypopituitarism.
    Juhan-Vague I; Conte-Devolx B; Aillaud MF; Mendez C; Oliver C; Collen D
    Thromb Res; 1984 Mar; 33(6):653-9. PubMed ID: 6609451
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of desmopressin (DDAVP) in the detection of decreased fibrinolytic capacity in persons with idiopathic venous thrombosis and myocardial infarct at a young age].
    Cepelák V; Dvorák J
    Vnitr Lek; 1985 Mar; 31(3):232-9. PubMed ID: 4036009
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of DDAVP on plasma levels of factor VII and XII.
    Brommer EJ; Kluft C; Bertina RM; Alderkamp GH
    Br J Haematol; 1984 May; 57(1):173-5. PubMed ID: 6426497
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparative study using immunological and biological assay of the haemostatic responses to DDAVP infusion venous occlusion and exercise in normal men.
    Prowse CV; Farrugia A; Boulton FE; Tucker J; Ludlam CA; McLaren M; Belch JJ; Prentice CR; Dawes J; MacGregor IR
    Thromb Haemost; 1984 Feb; 51(1):110-4. PubMed ID: 6426076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental studies of the liberation of plasminogen activator by DDAVP].
    Jablonowski C; Klöcking HP; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):567-74. PubMed ID: 6083928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inability of propranolol and aspirin to inhibit the response of fibrinolytic activity and factor VIII-antigen to infusion of DDAVP.
    Brommer EJ; Derkx FH; Barrett-Bergshoeff MM; Schalekamp MA
    Thromb Haemost; 1984 Feb; 51(1):42-4. PubMed ID: 6426080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of plasma prorenin by plasminogen activators in vitro and increase in plasma renin after stimulation of fibrinolytic activity in vivo.
    Derkx FH; Brommer EJ; Boomsma F; Schalekamp MA
    Neth J Med; 1984; 27(4):124-8. PubMed ID: 6377102
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on C1 inactivator resistant fibrinolytic activity].
    Deguchi A; Kawamura K; Deguchi K; Tamaki S; Tanigawa M; Iwasaki E; Wada H; Murashima S; Nishikawa M; Shirakawa S
    Rinsho Byori; 1991 May; 39(5):517-22. PubMed ID: 2072575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of deamino-8-D-arginine vasopressin on urinary prostaglandins E2 and F2 alpha excretion.
    Walker L; Frölich JC
    Adv Prostaglandin Thromboxane Res; 1980; 7():1107-9. PubMed ID: 7369023
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of arginine-8-vasopressin and 1-deamino-8-D-arginine-vasopressin on ACTH secretion in rats.
    László FA; Janáky T; Julesz J; Kárteszi M; Makara GB; Stark E
    Endocrinol Exp; 1983 Jun; 17(2):133-6. PubMed ID: 6309504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Desmopressin acetate - a new antidiuretic].
    S Afr Med J; 1979 Jan; 55(1):2. PubMed ID: 424908
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on kidney function in subjects exposed to organic solvents. II. The effect of desmopressin in a concentration test and the effect of exposure to organic solvents on renal concentrating ability.
    Askergren A; Allgën LG; Bergström J
    Acta Med Scand; 1981; 209(6):485-8. PubMed ID: 7257866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypofibrinolysis and thrombophilia].
    Cepelák V; Dvorák J; Cepeláková H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):456-67. PubMed ID: 6083911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of desmopressin acetate (DDAVP) as a test of the fibrinolytic capacity of patients--analysis of responders and non-responders.
    Brommer EJ; Barrett-Bergshoeff MM; Allen RA; Schicht I; Bertina RM; Schalekamp MA
    Thromb Haemost; 1982 Oct; 48(2):156-61. PubMed ID: 6817444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced response of uraemic bleeding time to repeated doses of desmopressin.
    Canavese C; Salomone M; Pacitti A; Mangiarotti G; Calitri V
    Lancet; 1985 Apr; 1(8433):867-8. PubMed ID: 2858723
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparative study of venous occlusion and DDAVP stimulated fibrinolysis in normolipidemic subjects.
    Smith P; Arnesen H; Dahl KH; Nilsen DW; Opstad T; Andersen P
    Thromb Res; 1988 Dec; 52(6):655-60. PubMed ID: 3148209
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.